Avianca May Get ‘Lifesaver’ Aid as Colombia Mulls Equity Stakes
(Bloomberg) -- An emergency measure allowing Colombia's government to take equity stakes in private companies opens the door for a bailout of the nation's largest airline, Avianca Holdings SA, which declared bankruptcy last month amid an unprecedented downturn in travel.
The new regulation, which permits the government to take minority positions in companies that have been impacted by the sharp economic downturn, “can be a lifesaver for Avianca,” said Carlos Enrique Rodriguez, director of equity research at Ultraserfinco SA, a brokerage.
The decree announcing the measure, which was posted to the presidency's website Friday, didn't say how much the government is willing to invest or identify specific companies that may be eligible. But Finance Minister Alberto Carrasquilla said last month that the government would look to help the carrier “in some way.” Shareholders may be required to buy back the government stake after a certain time, according to the decree.
A company spokeswoman didn't immediately respond to a request for comment.
Avianca filed for Chapter 11 protection from creditors in New York in May after grounding its fleet as Latin American countries closed down to stem the spread of the coronavirus. Colombia prohibited air travel starting in March and plans to restrict international flights through August in one of the region's most onerous bans.
Avianca plans to continue operating while it restructures under bankruptcy protection, once governments lift bans. A state investment, which may only come after a restructuring, would help the company keep operating, paying pilots and save jobs, Rodriquez said.
While Latin America has been particularly hard hit by the downturn in air travel amid the pandemic -- with flights falling more than 90% since the start of the year -- governments have provided scant support to carriers. Avianca's competitor Latam Airlines Group SA, the region's largest airline, was also forced to seek bankruptcy protection.
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
